Free shipping on all orders over $ 500

CFTRinh-172

Cat. No. M2504
CFTRinh-172 Structure
Synonym:

CFTR inhibitor 172

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
2mg USD 40  USD40 In stock
5mg USD 60  USD60 In stock
10mg USD 110  USD110 In stock
25mg USD 200  USD200 In stock
50mg USD 350  USD350 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
Biological Activity

CFTRinh-172 is a voltage-independent, selective CFTR inhibitor with Ki of 300 nM, showing no effects on MDR1, ATP-sensitive K+ channels, or a series of other transporters.

Customer Product Validations & Biological Datas
Source Oncotarget (2017). Figure 3. CFTRinh-172
Method Western-blot assay
Cell Lines K562 cells
Concentrations 20–50 μM
Incubation Time 24 h
Results Consistent with the results obtained using imatinib, CFTRinh-172 led to a significant reduction in p-BCR-ABL in both K562 and SUP-B15 cells as well as significant down-regulation oft-BCR-ABL in K562 cells (Figure 3A) but not in SUP-B15 cells (Figure 3C).
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 409.4
Formula C18H10F3NO3S2
CAS Number 307510-92-5
Purity >99%
Solubility DMSO 40 mg/mL
Storage at -20°C
References

[1] Mingfeng Liu, et al. Treatment of human T-cell acute lymphoblastic leukemia cells with CFTR inhibitor CFTRinh-172

[2] N Melis, et al. Revisiting CFTR inhibition: a comparative study of CFTRinh -172 and GlyH-101 inhibitors

[3] David N Sheppard. CFTR channel pharmacology: insight from a flock of clones. Focus on "Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101"

[4] Maximilian Stahl, et al. Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101

[5] Zoia Kopeikin, et al. On the mechanism of CFTR inhibition by a thiazolidinone derivative

Related CFTR Products
CP-628006

The CFTR potentiator CP-628006 enhances CFTR function in cystic fibrosis patient-derived air chamber cells by a mechanism of action different from that of existing potentiators such as ivacaftor.

Icenticaftor

Icenticaftor (QBW251) is an oral enhancer of the cystic fibrosis transmembrane conductance regulator (CFTR) channel with an EC50 of 79 nM for F508del and 497 nM for G551D CFTR. Icenticaftor can be used in chronic obstructive pulmonary disease (COPD) and cystic fibrosis studies.

NJH-2-057

NJH-2-057 is a conjugate of the deubiquitinase OTUB1 covalent ligand-linked lumacaftor, which stabilizes mutant CFTR proteins in cells.

GLPG2451

GLPG2451 is an enhancer of cystic fibrosis transmembrane conductance regulator (CFTR) and effectively enhances cryo-rescued F508del CFTR with an EC50 of 11.1 nM.

FDL169

FDL169 is a CFTR corrector that is designed to fix and restore the function of the defective CFTR protein.

  Catalog
Abmole Inhibitor Catalog




Keywords: CFTRinh-172, CFTR inhibitor 172 supplier, CFTR, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.